The soluble receptor ST2 is positively associated with occupational exposure to radiation

References

• Baker JE, Moulder JE, Hopewell JW. 2011. Radiation as a risk factor for cardiovascular disease. Antioxidants Redox Signaling 15:1945–1956.
   PubMed Web of Science ®Google Scholar
• Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer M, Mueller T. 2009. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma – the Presage ST2 assay. Clinica Chimica Acta 409:33–40.
   PubMed Web of Science ®Google Scholar
• Glass CK, Witztum JL. 2001. Atherosclerosis. The road ahead. Cell 104:503–516.
   PubMed Web of Science ®Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. 2003. Role of oxidative stress in atherosclerosis. Am J Cardiol 91:7A–11A.
   PubMed Web of Science ®Google Scholar
• Ivanova KG, Stankova KG, Nikolov VN, Georgieva RT, Minkova KM, Gigova LG, Rupova IT, Boteva RN. 2010. The biliprotein C-phycocyanin modulates the early radiation response: A pilot study. Mutati Res 695:40–45.
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr, Peacock WF, Maisel AS, Chae CU, Jesse RL, Baggish AL, O’Donoghue M, Sakhuja R, Chen AA, van Kimmenade RR, Lewandrowski KB, Lloyd-Jones DM, Wu AH. 2007. Measurement of the interleukin family member ST2 in patients with acute dyspnea: Results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50:607–613.
   PubMed Web of Science ®Google Scholar
• Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. 2005. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: Implications for the mitochondrial theory of aging. FASEB J 19:419–421.
   PubMed Web of Science ®Google Scholar
• Kakkar R, Lee RT. 2008. The IL-33/ST2 pathway: Therapeutic target and novel biomarker. Nature Rev Drug Discovery 7:827–840.
   PubMed Web of Science ®Google Scholar
• Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, Dries DL, Tang WH, Wu AH, Fang JC, Boxer R, Sweitzer NK, Levy WC, Goldberg LR, Jessup M, Cappola TP. 2011. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circulation. Heart Failure 4:180–187.
   PubMed Web of Science ®Google Scholar
• Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Paris F, Tapio S, Elliott P. 2010. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environmental Biophys 49:139–153.
   PubMed Web of Science ®Google Scholar
• Lu J, Snider JV, Grenache DG. 2010. Establishment of reference intervals for soluble ST2 from a United States population. Clinica Chimica Acta 411:1825–1826.
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA, Ordonez-Llanos J, Tornel PL, Vazquez R, Puig T, Valdes M, Cinca J, de Luna AB, Bayes-Genis A. 2009. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol 54:2174–2179.
   PubMed Web of Science ®Google Scholar
• Rehman SU, Mueller T, Januzzi JL Jr. 2008. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52:1458–1465.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Manas L, El-Assar M, Vallejo S, Lopez-Doriga P, Solis J, Petidier R, Montes M, Nevado J, Castro M, Gomez-Guerrero C, Peiro C, Sanchez-Ferrer CF. 2009. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 8:226–238.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, Rifai N, Cannon CP, Gerszten RE, Lee RT. 2008. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117:1936–1944.
   PubMed Web of Science ®Google Scholar
• Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. 2007. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clinical Investigat 117:1538–1549.
   PubMed Web of Science ®Google Scholar
• Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RT. 2004. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109:2186–2190.
   PubMed Web of Science ®Google Scholar
• Stankova K, Ivanova K, Nikolov V, Aneva N, Georgieva R, Boteva R. 2013. Proteasome inhibition protects human peripheral blood mononuclear cells from radiation-induced oxidative stress. Int J Radiat Biol 89:493–500.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z, Smith K, Csiszar A. 2007. Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol. Heart Circulatory Physiol 293:H37–47.
   PubMed Web of Science ®Google Scholar
• Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. 2003. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107:721–726.
   PubMed Web of Science ®Google Scholar
• Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM, McInnes IB, Dargie HJ, McMurray JJ. 2010. Serum soluble ST2: A potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol 55:243–250.
   PubMed Web of Science ®Google Scholar
• Wojtczak-Soska K, Pietrucha T, Sakowicz A, Lelonek M. 2013. Soluble ST2 protein in chronic heart failure is independent of traditional factors. Arch Medical Science 9:21–26.
   PubMed Web of Science ®Google Scholar